Chronicle Companies and Blue Charm Adherence Announce Strategic Partnership to Advance Real-World Data in Commercial Applications

Chronicle Companies, a leader in specialized medical publishing, and Blue Charm Adherence, a pioneer in patient experience data and insights, are excited to announce a groundbreaking collaboration aimed at advancing the use of Real-World Data (RWD) in commercial applications within the healthcare sector. This partnership will leverage Blue Charm's innovative Patient Insights platform to enhance the effectiveness of healthcare resources, improve patient outcomes, and empower individuals to take control of their health.

With over 30 years of experience in providing healthcare professionals with actionable insights, Chronicle Companies has long been a trusted name in medical publishing. Their platforms, including The Chronicle of Skin & Allergy, Skin Spectrum Summit, and the National Pharmaceutical Congress (NPC), have consistently provided educational resources focused on dermatology and CNS health. By joining forces with Blue Charm, Chronicle aims to bring RWD to the forefront of medical content, ensuring that it plays a critical role in improving patient care.

The partnership will focus on integrating Blue Charm’s expertise in collecting patient experience data into a series of scientific supplements, newsletters, webinars, and podcasts. These resources will highlight the commercial applications of RWD, emphasizing its potential to create positive shifts in healthcare practices and patient outcomes. By bridging the gap between patient-driven insights and actionable medical content, the partnership will provide healthcare professionals with the tools they need to better serve their patients.

Dr. Greg Patey, CEO of Blue Charm Adherence, shared his excitement for the collaboration, stating, “The time has come for us to harness the rich data that we gather from RWD and move beyond traditional clinical data. To truly understand the patient, you need to ask the patient and cultivate a longitudinal relationship that informs better care decisions.”

Mitchell Shannon, CEO and Publisher at Chronicle Companies, echoed these sentiments, noting, “Regulators, clinicians, and practitioners have increasingly recognized the value of real-world data and evidence in driving better care and outcomes. Chronicle’s core competency is translating data into actionable knowledge and practice. We’re thrilled to partner with Blue Charm to amplify ‘Ideas in the Service of Medicine’ and further extend the value of RWD across healthcare systems.”

This collaboration marks a significant step forward in the integration of real-world data into the healthcare ecosystem. By combining the strengths of both organizations, the partnership will help advance the field of patient-centred care while empowering healthcare professionals with the insights needed to deliver improved outcomes.

For more information, please contact Greg Patey at g.patey@bluecharm.io